PNC Financial Services Group’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-73
Closed -$2K 4340
2021
Q1
$2K Hold
73
﹤0.01% 3995
2020
Q4
$1K Hold
73
﹤0.01% 3937
2020
Q3
$2K Hold
73
﹤0.01% 3837
2020
Q2
$6K Hold
73
﹤0.01% 3617
2020
Q1
$5K Hold
73
﹤0.01% 3620
2019
Q4
$6K Buy
+73
New +$5.12K ﹤0.01% 3641
2018
Q4
Sell
-75
Closed -$87K 4240
2018
Q3
$87K Buy
+75
New +$69.1K ﹤0.01% 2678
2016
Q2
Sell
-5
Closed -$2K 4575
2016
Q1
$2K Hold
5
﹤0.01% 4244
2015
Q4
$3K Hold
5
﹤0.01% 4070
2015
Q3
$4K Buy
+5
New +$4.56K ﹤0.01% 4072

Other funds holding HSTO

PNC Financial Services Group's HSTO Position: Q2 2021 in Review

PNC Financial Services Group sold out of Histogen Inc. Common Stock (HSTO) in Q2 2021, closing a stake of 73 shares — an estimated $2K sold.

PNC Financial Services Group first reported a position in HSTO in Q3 2015 and held it in 10 quarters. The position peaked at $87K in Q3 2018. 24 funds tracked by Wall St. Rank hold HSTO as of Q2 2021.

  • PNC Financial Services Group reported no remaining Histogen Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • PNC Financial Services Group sold 73 Histogen Inc. Common Stock shares in Q2 2021, an estimated $2K.
  • PNC Financial Services Group first reported a position in Histogen Inc. Common Stock in Q3 2015 and held it in 10 quarters.
  • PNC Financial Services Group's Histogen Inc. Common Stock position peaked at $87K in Q3 2018.
  • 24 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2021.

Based on PNC Financial Services Group's 13F filing for Q2 2021, filed 6 Aug 2021.